Latest Prosight Management, LP Stock Portfolio
Prosight Management, LP Performance:
2024 Q3: -2.77%YTD: -16.41%2023: -2.77%
Performance for 2024 Q3 is -2.77%, and YTD is -16.41%, and 2023 is -2.77%.
About Prosight Management, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Prosight Management, LP reported an equity portfolio of $406.4 Millions as of 30 Sep, 2024.
The top stock holdings of Prosight Management, LP are ADCT, , BBIO. The fund has invested 7.5% of it's portfolio in ADC THERAPEUTICS SA and 7.3% of portfolio in GALAPAGOS NV.
The fund managers got completely rid off KELLY SVCS INC (KELYA), ALKERMES PLC (ALKS) and ORTHOPEDIATRICS CORP (KIDS) stocks. They significantly reduced their stock positions in IMMUNEERING CORP (IMRX), VIKING THERAPEUTICS INC (VKTX) and IMMUNOME INC (IMNM). Prosight Management, LP opened new stock positions in MCKESSON CORP (MCK), JANUX THERAPEUTICS INC (JANX) and HAEMONETICS CORP MASS (HAE). The fund showed a lot of confidence in some stocks as they added substantially to ABCELLERA BIOLOGICS INC (ABCL), DEXCOM INC (DXCM) and NEUROCRINE BIOSCIENCES INC (NBIX).
The top stock holdings of Prosight Management, LP are ADCT, , BBIO. The fund has invested 7.5% of it's portfolio in ADC THERAPEUTICS SA and 7.3% of portfolio in GALAPAGOS NV.
The fund managers got completely rid off KELLY SVCS INC (KELYA), ALKERMES PLC (ALKS) and ORTHOPEDIATRICS CORP (KIDS) stocks. They significantly reduced their stock positions in IMMUNEERING CORP (IMRX), VIKING THERAPEUTICS INC (VKTX) and IMMUNOME INC (IMNM). Prosight Management, LP opened new stock positions in MCKESSON CORP (MCK), JANUX THERAPEUTICS INC (JANX) and HAEMONETICS CORP MASS (HAE). The fund showed a lot of confidence in some stocks as they added substantially to ABCELLERA BIOLOGICS INC (ABCL), DEXCOM INC (DXCM) and NEUROCRINE BIOSCIENCES INC (NBIX).
Prosight Management, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Prosight Management, LP made a return of -2.77% in the last quarter. In trailing 12 months, it's portfolio return was -5.26%.
New Buys
| Ticker | $ Bought |
|---|---|
| mckesson corp | 17,711,100 |
| janux therapeutics inc | 9,313,150 |
| haemonetics corp mass | 5,224,700 |
| livanova plc | 4,728,600 |
| blueprint medicines corp | 4,356,750 |
| cytomx therapeutics inc | 3,566,090 |
| sight sciences inc | 3,346,700 |
| rocket pharmaceuticals inc | 2,943,540 |
New stocks bought by Prosight Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| abcellera biologics inc | 285 |
| dexcom inc | 224 |
| neurocrine biosciences inc | 129 |
| tectonic therapeutic inc | 103 |
| schrodinger inc | 89.57 |
| accolade inc | 88.09 |
| prothena corp plc | 68.5 |
| mirum pharmaceuticals inc | 47.97 |
Additions to existing portfolio by Prosight Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| immuneering corp | -65.45 |
| viking therapeutics inc | -58.26 |
| immunome inc | -39.79 |
| ovid therapeutics inc | -32.17 |
| erasca inc | -27.85 |
| galapagos nv | -23.79 |
| zymeworks inc | -22.24 |
| cogent biosciences inc | -17.83 |
Prosight Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| kelly svcs inc | -10,541,000 |
| biocryst pharmaceuticals inc | -2,463,970 |
| relay therapeutics inc | -2,510,200 |
| alkermes plc | -6,627,500 |
| paragon 28 inc | -1,787,980 |
| option care health inc | -5,678,500 |
| orthopediatrics corp | -5,758,210 |
| biomea fusion inc | -559,697 |
Prosight Management, LP got rid off the above stocks
Sector Distribution
Prosight Management, LP has about 88.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 88.1 |
| Others | 11.9 |
Market Cap. Distribution
Prosight Management, LP has about 13.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 32.7 |
| MID-CAP | 24.4 |
| UNALLOCATED | 19.6 |
| LARGE-CAP | 13.6 |
| MICRO-CAP | 8.9 |
Stocks belong to which Index?
About 62.4% of the stocks held by Prosight Management, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 50.7 |
| Others | 37.6 |
| S&P 500 | 11.7 |
Prosight Management, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Prosight Management, LP
Prosight Management, LP has 41 stocks in it's portfolio. About 55.4% of the portfolio is in top 10 stocks. CRBP proved to be the most loss making stock for the portfolio. ROIV was the most profitable stock for Prosight Management, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 5.81 | 9,079,540 | 23,606,800 | added | 285 | ||
| ACCD | accolade inc | 2.65 | 2,801,600 | 10,786,200 | added | 88.09 | ||
| ACHC | acadia healthcare company in | 0.09 | 5,666 | 359,281 | new | |||
| ADCT | adc therapeutics sa | 7.47 | 9,636,240 | 30,354,100 | added | 0.69 | ||
| ADUS | addus homecare corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALKS | alkermes plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALRN | aileron therapeutics inc | 0.32 | 372,157 | 1,317,440 | added | 40.44 | ||
| BBIO | bridgebio pharma inc | 6.81 | 1,086,810 | 27,670,200 | added | 35.85 | ||
| BCRX | biocryst pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMEA | biomea fusion inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BPMC | blueprint medicines corp | 1.07 | 47,100 | 4,356,750 | new | |||
| COGT | cogent biosciences inc | 1.09 | 410,830 | 4,436,960 | reduced | -17.83 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.66 | 130,000 | 2,681,900 | new | |||
| CTMX | cytomx therapeutics inc | 0.88 | 3,022,110 | 3,566,090 | new | |||
| CVS | cvs health corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYTK | cytokinetics inc | 2.50 | 192,700 | 10,174,600 | reduced | -16.22 | ||
| DXCM | dexcom inc | 2.64 | 160,000 | 10,726,400 | added | 224 | ||
| ERAS | erasca inc | 1.33 | 1,984,010 | 5,416,350 | reduced | -27.85 | ||
| FNA | paragon 28 inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| HAE | haemonetics corp mass | 1.29 | 65,000 | 5,224,700 | new | |||